Literature DB >> 23135837

The surgical management of active ulcerative colitis complicated by Clostridium difficile infection.

Edward W Chu1, Brett L Ecker, Malika Garg, Celia M Divino.   

Abstract

INTRODUCTION: Clostridium difficile stool toxin is detected in 5-20 % of patients with acute exacerbations of ulcerative colitis (UC). There is little data regarding the safety of surgery for UC with concurrent C. difficile.
METHODS: A retrospective review was performed of 23 patients undergoing colectomy for refractory UC complicated by C. difficile infection between January 2002 and June 2012. Patients were stratified into those who completed a full antibiotic course for C. difficile infection prior to surgery (group A, n = 7) and those who proceeded directly to surgery (group B, n = 16). The primary endpoints of perioperative mortality, ICU requirement, reoperation, readmission, and surgical site infection were assessed within 30 days after surgery.
RESULTS: Postoperatively, no mortalities, ICU admissions, readmission, or reoperations occurred. One group A patient developed a superficial wound infection, which resolved with a course of outpatient antibiotics (14 vs. 0 %, p = 0.12). Average days until return of bowel function and average length of postoperative stay were comparable between group A and B (3.9 vs. 3.6 days, p = 0.70; 7.0 vs. 6.9 days, p = 0.87; respectively). Ninety-one percent of patients subsequently underwent ileal pouch-anal anastomosis.
CONCLUSION: Colectomy for ulcerative colitis complicated by C. difficile can be performed safely without completing a course of antibiotic therapy.

Entities:  

Mesh:

Year:  2012        PMID: 23135837     DOI: 10.1007/s11605-012-2031-2

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  14 in total

1.  Impact of Clostridium difficile infection in patients with ulcerative colitis.

Authors:  Revital Kariv; Udayakumar Navaneethan; Preethi G K Venkatesh; Rocio Lopez; Bo Shen
Journal:  J Crohns Colitis       Date:  2010-10-30       Impact factor: 9.071

2.  Incidence of Clostridium difficile infection in inflammatory bowel disease.

Authors:  Joseph F Rodemann; Erik R Dubberke; Kimberly A Reske; Da Hea Seo; Christian D Stone
Journal:  Clin Gastroenterol Hepatol       Date:  2007-03       Impact factor: 11.382

3.  Impact of hospital volume on postoperative morbidity and mortality following a colectomy for ulcerative colitis.

Authors:  Gilaad G Kaplan; Ellen P McCarthy; John Z Ayanian; Joshua Korzenik; Richard Hodin; Bruce E Sands
Journal:  Gastroenterology       Date:  2008-01-10       Impact factor: 22.682

Review 4.  The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings.

Authors:  Sahil Khanna; Darrell S Pardi
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2010-08       Impact factor: 3.869

5.  Postoperative complications and mortality following colectomy for ulcerative colitis.

Authors:  Shanika de Silva; Christopher Ma; Marie-Claude Proulx; Marcelo Crespin; Belle S Kaplan; James Hubbard; Martin Prusinkiewicz; Andrew Fong; Remo Panaccione; Subrata Ghosh; Paul L Beck; Anthony Maclean; Donald Buie; Gilaad G Kaplan
Journal:  Clin Gastroenterol Hepatol       Date:  2011-07-30       Impact factor: 11.382

6.  Epidemiology and natural history of inflammatory bowel diseases.

Authors:  Jacques Cosnes; Corinne Gower-Rousseau; Philippe Seksik; Antoine Cortot
Journal:  Gastroenterology       Date:  2011-05       Impact factor: 22.682

7.  Clostridium difficile infection in patients with ulcerative colitis: investigations of risk factors and efficacy of antibiotics for steroid refractory patients.

Authors:  Takashi Kaneko; Reikei Matsuda; Masataka Taguri; Masahiko Inamori; Asami Ogura; Eiji Miyajima; Katsuaki Tanaka; Shin Maeda; Hideaki Kimura; Reiko Kunisaki
Journal:  Clin Res Hepatol Gastroenterol       Date:  2011-03-23       Impact factor: 2.947

8.  Temporal trends in disease outcomes related to Clostridium difficile infection in patients with inflammatory bowel disease.

Authors:  Ashwin N Ananthakrishnan; Emily L McGinley; Kia Saeian; David G Binion
Journal:  Inflamm Bowel Dis       Date:  2010-09-07       Impact factor: 5.325

Review 9.  Clostridium difficile and inflammatory bowel disease.

Authors:  Mazen Issa; Ashwin N Ananthakrishnan; David G Binion
Journal:  Inflamm Bowel Dis       Date:  2008-10       Impact factor: 5.325

10.  Clinical outcomes of patients with ulcerative colitis and co-existing Clostridium difficile infection.

Authors:  Daniela Jodorkovsky; Yuki Young; Maria T Abreu
Journal:  Dig Dis Sci       Date:  2009-03-03       Impact factor: 3.199

View more
  2 in total

Review 1.  Clostridium difficile infection: guideline-based diagnosis and treatment.

Authors:  Christoph Lübbert; Endres John; Lutz von Müller
Journal:  Dtsch Arztebl Int       Date:  2014-10-24       Impact factor: 5.594

Review 2.  Management of inflammatory bowel disease with Clostridium difficile infection.

Authors:  Julie D'Aoust; Robert Battat; Talat Bessissow
Journal:  World J Gastroenterol       Date:  2017-07-21       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.